Overview of Tessalon

Property	Description
Active ingredient	Benzonatate
Form	Softgels or Capsules (Perles)
Pharmacological class	Antitussive Agent (Cough Suppressant)
Origin	Synthetic Compound
Rx Status	Prescription Only

What Type of Medicine is Tessalon (Benzonatate)?

Tessalon is a brand name for the prescription medication whose active ingredient is Benzonatate, formally classified as a non-narcotic antitussive agent. This compound is a synthetic ester chemically derived from the para-aminobenzoic acid (PABA) class, which structurally relates it to local anesthetics like procaine.

Benzonatate is pharmacologically distinctive as a peripherally acting suppressant. This means its mechanism of action is focused locally, primarily on the sensory receptors in the airways, differentiating it from centrally acting cough suppressants. This distinction is clinically recognized as supporting symptomatic relief without the addictive potential associated with opioid-based antitussives.

Identifying the Drug: Form and Mechanism Classification

Benzonatate is formulated for oral administration as a single-ingredient product contained within liquid-filled softgels or capsules, commonly known as perles. This specific delivery method is necessary for the drug’s local anesthetic property to reach the lower respiratory tract intact.

The mechanism relies on anesthetizing the pulmonary stretch receptors—specialized nerve fibers—located in the respiratory passages and lungs. By dampening the activity of these peripheral receptors, the medicine effectively reduces the sensory signals that initiate the cough reflex. This localized anesthetic effect begins to provide relief quickly, typically within 15 to 20 minutes following ingestion.

General Purpose: How Benzonatate Provides Cough Relief

The general purpose of Tessalon is to offer symptomatic relief of cough by decreasing the sensitivity of the respiratory tissues that trigger the reflex. This action provides relief without inhibiting the central respiratory drive at therapeutic concentrations. By targeting the source of the cough signal in the airways, Benzonatate successfully reduces the urge to cough, thereby facilitating comfort.

Regulatory References

What side effects are possible with Tessalon?

Possible Side Effects and Safety Information

The official regulatory documentation for Benzonatate lists potential adverse reactions across several physiological systems, though specific frequency classifications like common or uncommon are generally not defined in the primary prescribing information.

Adverse effects have been documented in various System-Organ Classes. Effects pertaining to the Nervous System include drowsiness, sedation, headache, dizziness, and confusion. Reactions affecting the Gastrointestinal System have been noted as nausea, constipation, and general gastrointestinal upset. Other documented effects include stuffy nose (nasal congestion) and skin reactions such as pruritus (itching), rash, and non-specific skin eruptions.

Serious Adverse Reactions and Safety Constraints

The official labeling identifies several potential serious adverse reactions. These include significant hypersensitivity reactions, which may progress to anaphylaxis. Other severe, acute reactions documented are bronchospasm and laryngospasm. In cases of accidental or excessive ingestion, documented severe outcomes have included convulsions, cardiovascular collapse, and death.

Safety constraints are outlined, primarily focusing on administration and specific populations. The medicine is contraindicated in individuals with a known hypersensitivity to Benzonatate or chemically related para-aminobenzoic acid (PABA) ester anesthetics. Because the drug possesses local anesthetic properties, if the softgel or capsule is chewed or dissolved in the mouth, this may cause a temporary, localized numbness of the mouth, tongue, or pharynx.

The regulatory profile also contains specific warnings regarding the risk associated with accidental ingestion, particularly in the pediatric population. The ingestion of a small number of softgels by children under ten has been documented to result in serious adverse events due to rapid toxicity. For use during pregnancy, the FDA classification is Pregnancy Category C.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Benzonatate describes a high-risk overdose profile with symptoms that can appear rapidly, typically within 15 to 20 minutes of ingestion.

Documented Overdose Manifestations

Overdose presentation begins with central nervous system (CNS) stimulation, including restlessness and tremors, which quickly progresses to profound CNS depression, leading to severe outcomes such as clonic convulsions, coma, and cerebral edema. Life-threatening effects include cardiac arrest and severe hypotension, with fatalities reported in both adults and children, often occurring within one hour.

When to Seek Immediate Medical Attention

Immediate medical attention is required for any suspected overdose or accidental ingestion. Caregivers are officially advised to contact a Poison Control Center and/or seek emergency medical attention without delay due to the potential for rapid progression.

Population and Treatment Considerations

The FDA specifically warns that accidental ingestion by children under 10 years of age can be fatal, with death reported after ingesting as few as one or two capsules. Furthermore, chewing or breaking the capsule can cause rapid oropharyngeal anesthesia and potential airway compromise.

No specific antidote is known for Benzonatate overdose. Treatment is symptomatic and supportive, focusing on managing convulsions, supporting respiratory and cardiovascular function, and procedures such as gastric content evacuation and activated charcoal administration.

Therapeutic Uses of Tessalon

The primary therapeutic role of this prescription agent is the symptomatic relief of cough. This prescription antitussive is applied across domains where additional symptomatic support is needed. It is used in contexts marked by increased discomfort and tension from a persistent, non-productive cough.

Relief of Non-Productive and Hacking Cough

Tessalon (Benzonatate) is commonly used to help with dry, hacking cough patterns and symptom clusters that may appear suddenly or fluctuate, such as those that are high-frequency or paroxysmal. It assists with managing symptoms related to inflammatory or irritative states that trigger the frequent urge to cough, which may assist with easing the overall symptom load.

The medicine is applied in clinical settings that involve acute or unstable symptom patterns, such as cough associated with the common cold, influenza, or acute bronchitis. It contributes to easing the overall symptom load during periods of heightened symptoms and is also considered relevant for easing symptoms related to chronic respiratory conditions characterized by periods of heightened symptoms, including emphysema and chronic bronchitis.

Quick Fact: Relief for Irritation-Induced Cough

Quick Fact: Relief for Irritation-Induced Cough. The medicine is relevant for managing symptoms related to inflammatory or irritative states, which may provide supportive assistance when symptoms interfere with routine activities.

Regulatory References

U.S. Food and Drug Administration (FDA) via DailyMed

Eligibility and Restrictions for Use

The eligibility to use Tessalon (benzonatate) is defined by the official population use classifications and contraindications documented in regulatory labeling.

Official Eligibility Status

Classification	Population Group	Regulatory Basis
Approved Population	Adults and adolescents aged 10 years and older.	Allowed Use
Absolute Prohibition	Children below the age of 10 years.	Contraindication
Absolute Prohibition	Patients with known sensitivity to benzonatate or PABA-type anesthetics (e.g., procaine).	Contraindication

The medicine is strictly contraindicated in children under 10 years of age. This prohibition is due to the fact that safety and effectiveness in this age group have not been established, and accidental ingestion has resulted in documented overdose and death.

Conditional Eligibility

Use during pregnancy is restricted (classified as Category C) and should only occur if the potential benefit clearly justifies the potential risk to the fetus, as adequate human studies are lacking. For nursing mothers, caution is advised because it is unknown whether the drug is excreted into human milk. The official prescribing information does not cite specific restrictions or dosage adjustments based on hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Benzonatate is defined by official statements regarding drug combinations and specific administration-timing restrictions. The regulatory documentation primarily classifies these as pharmacodynamic interactions and chemical-class related restrictions.

Drug–Drug Interactions and Restrictions

One documented interaction pattern is a pharmacodynamic interaction involving the co-administration of Benzonatate with other prescribed drugs. This combination has been associated in isolated reports with severe central nervous system effects, including bizarre behavior, mental confusion, and visual hallucinations.

The official profile also notes a restriction related to the drug’s chemical structure. Benzonatate is chemically similar to anesthetic agents of the para-amino-benzoic acid class, such as procaine and tetracaine. Combining the drug with these related anesthetic agents is restricted due to the documented potential for hypersensitivity reactions.

Administration-Timing Interactions

A critical rule governs the co-ingestion of Benzonatate with certain non-medicinal substances. If the capsule is compromised in the mouth, leading to numbness or tingling of the tongue, mouth, or throat, an administration-timing interaction with oral intake is created. In this circumstance, the ingestion of food or liquids must be temporarily stopped until the numbness completely resolves. This mandatory restriction is stated in the official labeling to prevent the potential risk of choking or airway compromise resulting from the localized anesthetic effect.

Mechanism of Action

Tessalon (Benzonatate) functions primarily as a local anesthetic, exhibiting selective affinity for sensory receptors within the respiratory tract. Following systemic absorption, the compound is distributed to the lower airway, concentrating in the pulmonary stretch receptors situated within the bronchi, alveoli, and pleura. The primary biological targets are voltage-gated sodium channels, specifically inhibiting the Nav1.7 subtype. This interaction is classified as an inhibitor or antagonist of channel function.

At the molecular level, this antagonism blocks the influx of sodium ions, thereby stabilizing the neuronal membrane and raising the threshold for action potential generation in the vagal afferent nerve fibers. This intracellular process dampens the mechanoreceptor activity of the pulmonary stretch receptors. The downstream cascade is a substantial reduction in afferent neural signaling transmitted via the vagus nerve toward the central cough center in the medulla. The system-level physiological consequence is the modulation of the cough reflex arc, resulting in decreased efferent output to the expiratory muscles.

Dosage and Administration Information

Administration Guidelines

Benzonatate is administered exclusively by the oral route using the softgel capsule, which is available in 100 mg, 150 mg, and 200 mg strengths. The standardized usage protocol mandates that the capsule be swallowed whole; it must not be chewed, broken, cut, dissolved, or crushed under any circumstance. This procedural constraint is critical for proper administration.

Dosage and Schedule

For adults and children 10 years of age and older, the usual dose is one 100 mg or 200 mg capsule, taken three times a day (t.i.d.) as required. The total daily intake is restricted to a maximum of 600 mg in any 24-hour period. Dosing is intended for short-term symptomatic use, as is typical for antitussive agents.

Administration Details

Administration Scope	Requirement
Route of Administration	Oral only
Standard Single Dose	100 mg or 200 mg capsule
Maximum Daily Dose	600 mg total
Dosing Frequency	Three times a day (t.i.d.)
Timing with Meals	Can be taken with or without food

Age and Missed Dose Rules

Use of Benzonatate is restricted to individuals 10 years of age and older; safety and efficacy have not been established for younger pediatric patients. In the event of a missed dose, the next scheduled dose should be taken at the regular time, and a double dose must not be taken to compensate for the skipped one. These precise dosage and procedural rules are established for the use of the medicine.

Recent Clinical Evidence

Tessalon: Recent Clinical Evidence

Evidence for Symptomatic Relief of Non-Productive Cough

Research for Tessalon (Benzonatate) has explored its use in managing non-productive cough, a condition characterized by episodic or acute changes. The evidence base includes older, historical controlled trials that provided the initial supporting data for the medicine's regulatory approval. These trials, often used in research exploring how symptoms change over time, examined outcomes related to physical discomfort, primarily measuring patient-reported changes in cough frequency and severity over defined time intervals.

More recently, the research landscape includes modern methodologies, such as new randomized, controlled trials (RCTs) and comprehensive systematic reviews of the existing data. These studies monitor outcomes reflecting daily functioning or activity level to understand the patterns observed in people experiencing these symptoms.

Study Quality and Scientific Assessment

Scientific bodies and systematic reviews have evaluated the overall quality and consistency of the existing evidence for Tessalon. Research has explored the rigor of the data used for the medicine's initial clearance, with findings indicating that the evidence is limited and generally considered low quality when judged against contemporary standards for clinical research. Because the earliest studies informing regulatory decisions do not align with the expectations for large-scale, modern trials, the overall certainty remains low.

The available evidence describes group patterns observed in the studies but must be viewed within the context of these methodological limitations.

Short-Term Findings and Measured Duration of Effect

The studies that have been conducted focused predominantly on research exploring short-term symptom changes. Research highlights changes measured during the study period regarding the timing of the medicine's activity. The timing of reported symptom change was monitored, with study results describing patterns related to an observed change beginning within 15 to 20 minutes following ingestion.

Similarly, the duration of the observed symptom change was monitored, with measurements spanning approximately three to eight hours. Study results reflect the specific conditions under which they were conducted. Long-term effects are not fully established through the available research.

Research for Use in Specific Populations

Research examined primarily adult populations (age 18 and older) who had conditions involving periods of heightened symptoms. However, data for certain groups remain insufficient to characterize the observed symptom changes.

Children: The extent of symptom change has not been established for the regulatory cutoff of children below 10 years of age.
Older Adults: Limited information for long-term outcomes or short-term symptom change is available for the geriatric population.
Underlying Conditions: Early studies described populations that included patients with various underlying respiratory conditions in the original research context.

Unanswered Questions and Research Gaps

The evidence base highlights what is known — and what is still uncertain about this medicine.

Follow-up durations were limited in most efficacy studies, meaning there is limited information for long-term outcomes or how the effects hold up over extended periods.
The historical literature utilized sample sizes that were modest; research provides insight into short-term changes but is not predictive of individual response.
Scientific and regulatory analysis indicates a recognized need for new, large-scale RCTs to characterize observed outcomes in contemporary clinical settings. Comparative evidence is lacking, and evidence quality varies across studies, leading to certainty remaining low for the overall evidence base. The research provides context but does not determine whether an individual will respond similarly.

Key Studies & References

Benzonatate Capsule, U.S.P. (Official FDA Label via DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Tessalon (FAQ)

Q: Is Tessalon the same as a cough syrup or another over-the-counter medicine?

According to official product information, Tessalon (benzonatate) is a prescription-only medication supplied as liquid-filled softgel capsules, often called 'perles.' It is not available over the counter like many common cough suppressants.

Q: Is it possible to become dependent on Tessalon?

Regulatory documents classify the active ingredient, benzonatate, as a non-narcotic antitussive. This designation indicates that the drug does not carry the addictive potential associated with opioid-based (narcotic) cough suppressants.

Q: Is there a maximum number of days Tessalon is usually taken?

Official usage guidelines indicate that Tessalon is intended for short-term symptomatic relief of cough. The duration of use is typically guided by the prescribing healthcare professional.

Q: Can people who have kidney issues take Tessalon?

The official prescribing information does not contain specific restrictions or recommended dosage adjustments for patients who have kidney (renal) impairment. The labeling does not indicate specific dosage adjustments for this condition.

Q: Does Tessalon affect the central nervous system?

While the drug is known to act primarily in the chest (peripherally), the official labeling reports potential effects on the central nervous system (CNS). These can include drowsiness, dizziness, headache, and mental confusion. Severe CNS effects have also been reported in isolated instances when taken with other prescribed drugs.

Q: What are the most commonly reported side effects of Tessalon?

The official documentation lists various potential adverse reactions, such as nausea, dizziness, and sedation. However, the prescribing information generally does not define specific frequency classifications (e.g., common or uncommon) for these effects.

Q: Can Tessalon affect my ability to drive or operate machinery?

Tessalon can cause side effects such as drowsiness, sedation, and dizziness. Regulatory documents suggest that caution should be used when determining whether to drive or operate machinery while taking the medication.

Q: Are there specific symptoms that mean I should stop taking Tessalon immediately?

Serious reactions have been documented, including bronchospasm (severe airway tightening) and laryngospasm (throat spasm). In cases of severe allergic reactions or sudden difficulty breathing, immediate medical attention is reported as being necessary.

Q: Do older adults (senior citizens) need special considerations for Tessalon?

Official information indicates that the safety and effectiveness of the medicine have not been fully established through specific research in patients over 65 years of age. Data regarding long-term outcomes for this population remain limited.

Q: Is Tessalon available over the counter in some countries?

The drug is designated as 'Rx Only' (prescription-only) in the United States. Its classification as a prescription drug is maintained in official US labeling.

Q: What are the official warnings about taking Tessalon with other medications that cause sedation?

The official label warns that taking benzonatate in combination with other prescribed drugs has been associated with isolated reports of severe CNS effects, including bizarre behavior and mental confusion. This includes medications that may affect the central nervous system.

Q: Are there any long-term side effects associated with Tessalon use?

The medication is indicated for short-term symptomatic use, and official documentation primarily covers short-term safety data. Specific information regarding the medicine’s long-term effects is limited.

Q: Does Tessalon help with a dry cough or a cough with mucus?

Benzonatate is indicated for the symptomatic relief of cough. It is generally prescribed for a non-productive cough, which is typically described as a dry cough without the presence of mucus or phlegm.

Q: Can a person with liver problems safely use Tessalon?

The official prescribing information does not contain specific restrictions or recommended dosage adjustments for patients who have liver (hepatic) impairment. The labeling does not indicate specific dosage adjustments for this condition.

Q: Can I take Tessalon if I am already taking an antidepressant?

The official label warns of severe CNS effects, such as confusion, when benzonatate is combined with other prescribed drugs. It is important that the prescriber is informed of all medications being taken, including antidepressants.

Q: Does alcohol interact with Tessalon?

While the US labeling does not specifically name alcohol, official warnings about potential CNS side effects, such as drowsiness and dizziness, exist. The potential exists for these side effects to be worsened when combined with substances like alcohol that also affect the central nervous system.

Q: Can Tessalon be taken with common cold and flu medications?

Caution is advised when combining benzonatate with common cold or flu medicines that contain ingredients which cause drowsiness or sedation (for example, certain antihistamines). This combination may increase the risk of CNS side effects.

Q: Is Tessalon used for purposes other than cough suppression?

According to official documentation, the active ingredient benzonatate is indicated and approved only for the symptomatic relief of cough. The label does not list other approved uses.

Q: Is Tessalon a treatment for the underlying cause of the cough?

Benzonatate is indicated for the symptomatic relief of cough. This means it helps control the symptom itself, but it does not treat the underlying medical condition that is causing the cough.

Q: Does Tessalon contain any common allergens like gluten or lactose?

The capsule contains inactive ingredients such as gelatin and glycerin. The official regulatory labeling does not explicitly state the presence or absence of specific common allergens like gluten or lactose. The full ingredient list is available upon request from the manufacturer.

Q: Has Tessalon been recalled or flagged for safety issues recently?

The FDA has issued specific Drug Safety Communications regarding the serious risk of overdose and death from accidental ingestion in children under 10 years of age. Patients are advised to check official FDA sources for the most current safety alerts and warnings.

How should Tessalon be stored and disposed of?

How to Store and Dispose of Tessalon (Benzonatate)

Tessalon capsules must be stored according to specific regulatory requirements to ensure product stability and safety.

Storage Conditions

Requirement	Details
Temperature	Store at Controlled Room Temperature, defined as 20 to 25 C (68 to 77 F).
Protection	The capsules must be protected from light and must not be frozen.
Packaging	The medicine must be kept in a tight, light-resistant container.
Child Safety	Due to the risk of accidental ingestion, the product must be stored in a child-resistant container and kept out of reach of children.

Disposal Instructions

Expired or unused Tessalon should be disposed of in a way that prevents access by children or pets. Official guidance recommends mixing the capsules with an undesirable substance, such as coffee grounds or kitty litter, and then placing this mixture into a sealed container before discarding it in the trash. The medication should not be flushed down a toilet or poured into a drain.

Tessalon